Trends in the development of MET inhibitors for hepatocellular carcinoma. [electronic resource]
- Future oncology (London, England) May 2016
- 1275-86 p. digital
Publication Type: Journal Article; Review
1744-8301
10.2217/fon.16.3 doi
Antineoplastic Agents--therapeutic use Carcinoma, Hepatocellular--drug therapy Humans Liver Neoplasms--drug therapy Molecular Targeted Therapy Protein Kinase Inhibitors--therapeutic use Proto-Oncogene Proteins c-met--antagonists & inhibitors